民间社会组织在免疫接种中的作用:范围综述
本范围综述遵循PRISMA-SCR指南,检索多个数据库及灰色文献,纳入148篇出版物中的250个民间社会组织(CSO)案例研究,综合其在一级免疫接种中的角色,并比较常规与脆弱冲突地区(FCV)的差异。CSO承担需求生成、服务提供等多领域角色,在FCV地区更侧重服务提供。加强CSO参与需要灵活长期资金、清晰协调及认可其多样性。
要点
- CSO在免疫接种中承担需求生成、服务提供、研究监测等多领域角色。
- FCV地区CSO参与侧重服务提供,常规地区角色更多样。
- 需灵活长期资金、清晰协调及直接支持本地CSO以推进IA2030。
核心结论
- CSO是免疫接种的多领域合作伙伴,通过社区覆盖、技术专长和适应性补充政府努力,其多样性带来独特优势。
研究设计与样本
- 遵循PRISMA-SCR和Joanna Briggs指南的范围综述,检索OVID MEDLINE、OVID Global Health、Global Index Medicus、Web of Science、Scopus及灰色文献,纳入148篇出版物中的250个CSO案例研究,采用迭代归纳主题综合法分析。
主要发现
- 案例多来自非洲和亚洲的低收入及中低收入国家,超过三分之一涉及国际非政府组织(INGO)。
- 报告的角色包括需求生成(121例;48.4%)、免疫服务提供(97例;38.8%)、研究/创新/监测(89例;35.6%)、免疫系统强化(77例;30.8%)、倡导/政策参与(53例;21.2%)、多部门协调/整合(45例;18.0%)和资源动员(13例;5.2%)。
- 在FCV地区(42/250例),参与侧重服务提供,而在208例常规免疫案例中角色更多样。
关键数值与推荐
- 需求生成占48.4%(121/250),免疫服务提供占38.8%(97/250),研究/创新/监测占35.6%(89/250),免疫系统强化占30.8%(77/250),倡导/政策参与占21.2%(53/250),多部门协调/整合占18.0%(45/250),资源动员占5.2%(13/250)。
- FCV地区案例42例,常规免疫案例208例。
临床怎么用
- 政策制定者和资助者应部署公平灵活的资金(包括对本地CSO的直接可预测支持),投资本地能力和数据系统,并将CSO纳入卫生系统治理和问责机制。
- 未来研究应比较不同角色在何种环境及情境下有效。
局限性
- 证据碎片化于不同环境和CSO类型,限制其对免疫政策、筹资、治理和CSO参与的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVES: Civil society organisations (CSOs) are central to reaching zero-dose children and advancing Immunisation Agenda 2030 (IA2030). Yet the evidence on CSO roles is fragmented across settings and CSO types, limiting its value for shaping immunisation policy, financing, governance and CSO engagement. We synthesised global evidence on CSO roles in childhood immunisation, compared routine versus fragile, conflict-affected and vulnerable (FCV) settings, and identified reported barriers and gaps in CSO engagement. METHODS: Following PRISMA-SCR Joanna Briggs guidelines, we searched OVID MEDLINE, OVID Global Health, Global Index Medicus, Web of Science, Scopus and grey literature. Eligible full texts were charted in Excel and analysed using an iterative, inductive thematic synthesis. RESULTS: We included 250 CSO case studies reported in 148 publications, mostly from low- and lower-middle-income countries in Africa and Asia. Over one-third of cases involved international non-governmental organisations (INGOs). Roles reported were demand generation (121; 48.4%), immunisation service delivery (97; 38.8%), research/innovation/monitoring (89; 35.6%), immunisation system strengthening (77; 30.8%), advocacy/policy engagement (53; 21.2%), multi-sectoral coordination/integration (45; 18.0%), and resource mobilisation (13; 5.2%). In FCV settings (42/250), engagement focused on service delivery (Bowes, 1967 [28]), whereas in 208 routine immunisation cases, roles were more diverse. CONCLUSION: CSOs are integral partners performing multi-domain roles and complementing government efforts through community reach, technical expertise, and adaptability. They are diverse and bring unique strengths. Stronger CSO engagement will require flexible, longer-term funding, clearer coordination, and recognition of distinct CSO roles and types. To achieve IA2030, policymakers and funders should deploy equitable, flexible financing (including direct, predictable support to local CSOs), invest in local capacity and data systems, and include CSOs in governance and accountability mechanisms across the health system. Future research should compare which roles work, where, and in what contexts.
引用
- Shrestha S, Wiley K, Tinessia A, et al. Role of civil society organisations in immunisation: A scoping review. Vaccine. 2026. PMID: 42537289. doi:10.1016/j.vaccine.2026.128982
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。